Polyphenols and betalains are bioactive compounds found in a variety of plants, seeds, roots, fruits, and foods, and have been extensively studied for their potential health benefits. These compounds have shown promise in mitigating metabolic diseases, including obesity and metabolic syndrome, which are prevalent worldwide. Current research has demonstrated that flavonoids, a subgroup of polyphenols, can positively influence cardiovascular health, the nervous system, and metabolic parameters such as lipid profiles, blood pressure, and blood glucose levels. Despite these promising findings, there remain significant gaps in our understanding of the precise mechanisms through which these compounds exert their effects, particularly in relation to their interaction with gut microbiota and their bioavailability. Addressing these gaps is crucial for developing effective dietary strategies to combat metabolic diseases.
This research topic aims to explore the intricate associations between polyphenols and betalains and their mechanisms of action, including hypolipidemic, hypoglycemic, antiproliferative, anti-inflammatory, and antioxidant effects. Additionally, it seeks to investigate how these compounds modulate gut microbiota and their bioavailability, ultimately impacting obesity and metabolic syndrome. By answering these questions, the research aims to build a bridge between functional foods and disease treatment, providing a scientific basis for using foods rich in polyphenols and betalains to prevent and treat metabolic diseases.
To gather further insights into the role of polyphenols and betalains in obesity and metabolic syndrome, we welcome articles addressing, but not limited to, the following themes:
• Novel methods for discovering bioactive polyphenols and betalains in foods (plants, roots, seeds, fruits, and foods)
• Pharmacological effects of polyphenols and betalains that alleviate or prevent obesity and metabolic syndrome
• Identification of traditional foods associated with polyphenols and betalains involved in the search for promising treatments for the prognosis or prevalence of obesity and metabolic syndrome
• Flavonoids-environment interactions between gut microbiota and metabolic diseases
• In vivo/vitro models or clinical investigations to better understand the role of flavonoids in health-promoting effects in metabolic diseases
Polyphenols and betalains are bioactive compounds found in a variety of plants, seeds, roots, fruits, and foods, and have been extensively studied for their potential health benefits. These compounds have shown promise in mitigating metabolic diseases, including obesity and metabolic syndrome, which are prevalent worldwide. Current research has demonstrated that flavonoids, a subgroup of polyphenols, can positively influence cardiovascular health, the nervous system, and metabolic parameters such as lipid profiles, blood pressure, and blood glucose levels. Despite these promising findings, there remain significant gaps in our understanding of the precise mechanisms through which these compounds exert their effects, particularly in relation to their interaction with gut microbiota and their bioavailability. Addressing these gaps is crucial for developing effective dietary strategies to combat metabolic diseases.
This research topic aims to explore the intricate associations between polyphenols and betalains and their mechanisms of action, including hypolipidemic, hypoglycemic, antiproliferative, anti-inflammatory, and antioxidant effects. Additionally, it seeks to investigate how these compounds modulate gut microbiota and their bioavailability, ultimately impacting obesity and metabolic syndrome. By answering these questions, the research aims to build a bridge between functional foods and disease treatment, providing a scientific basis for using foods rich in polyphenols and betalains to prevent and treat metabolic diseases.
To gather further insights into the role of polyphenols and betalains in obesity and metabolic syndrome, we welcome articles addressing, but not limited to, the following themes:
• Novel methods for discovering bioactive polyphenols and betalains in foods (plants, roots, seeds, fruits, and foods)
• Pharmacological effects of polyphenols and betalains that alleviate or prevent obesity and metabolic syndrome
• Identification of traditional foods associated with polyphenols and betalains involved in the search for promising treatments for the prognosis or prevalence of obesity and metabolic syndrome
• Flavonoids-environment interactions between gut microbiota and metabolic diseases
• In vivo/vitro models or clinical investigations to better understand the role of flavonoids in health-promoting effects in metabolic diseases